Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

B-kompleks: Et nutraceutical SANS-mottiltak

9. november 2026 oppdatert av: Sara R. Zwart, PhD, National Aeronautics and Space Administration (NASA)

In this project, the investigators propose to test effectiveness of a daily nutraceutical supplement containing bioactive B vitamins to mitigate optic disc edema in astronauts. The proposed countermeasure is intended to maximize functioning of the one-carbon metabolic pathway to provide enough substrate and cofactors to overcome any genetic differences that may impact the efficiency of enzyme function. By optimizing the pathway, this will 1) optimize endothelial function by increasing eNOS coupling and nitric oxide synthesis and 2) optimize collagen firmness and elasticity in the sclera and lamina cribrosa, and 3) minimize changes in total retinal thickness during and after flight.

The protocol includes assessments of ocular health and function, along with determinants of vascular endothelial function, advanced glycation end products, and nutritional status and one carbon biochemistry. These additional measures will be critical for the further definition of the causes of optic disc edema in some astronauts after long-duration space flight, and in understanding the effect of the countermeasure. Finally, the supplemented subjects in this study will be compared against total retinal thickness data from previously flown astronauts known to have not taken supplements during their missions.

Studieoversikt

Status

Rekruttering

Detaljert beskrivelse

Fasting (8-h) blood samples (7.5 mL SST and 5 mL EDTA tubes, 12.5 mL total per session) will be collected approximately 180 days and 45 days before flight, and return to Earth +0-2 days and 30 days after landing.

Blood samples will be analyzed for vitamin status and one-carbon biochemistry, as previously described. One blood sample (collected before flight) will be analyzed for approximately 511 SNPs matching the profile of testing from our ongoing research related to optic disc edema. Serum samples will be analyzed for biochemistry measures evaluating endothelial function, vitamin status, and oxidative damage.

Nutritional status assessment data, including inflight dietary intake and body mass data, completed for routine medical requirements will be requested for data sharing. Inflight medical exercise log data as well as available standard measures data will also be requested for data sharing. Medication use/Med Logs will also be requested for data sharing.

Vascular function VENDYS-II (Endothelix, Inc) will be used to assess reactive hyperaemia through changes in fingertip temperature. The test consists of an automated blood pressure measurement followed by cuff occlusion of the right arm for 2 to 5 min. During this time, the fingertip temperature in the right hand decreases because of the lack of circulation in the fingertip. After the cuff is released, blood flow resumes, causing a temperature rebound in the fingertip in a manner that is proportional to vascular reactivity.

Advanced Glycation End (AGE) Products Skin autofluorescence (SAF) will be analyzed non-invasively using an AGE reader (Diagnoptics Technologies, Groningen, the Netherlands). The AGE reader illuminates a skin surface of approximately 4 cm2, guarded against surrounding light, with an excitation light source with wavelength between 300 and 429 nm. This method is based on the fluorescent properties of certain AGEs accumulated in dermal tissue.

OCT and OCT-A Optical coherence tomography (OCT) and OCT-angiography (OCT-A) scans will be acquired using the Spectralis OCT2 (Heidelberg Engineering) before, during, and after flight. The scan pattern includes 24 B-scans centered in a radial pattern over the optic nerve head, as well as a 3.5 mm circle scan surrounding the optic nerve head for assessment of retinal nerve fiber layer thickness and choroid thickness. For OCT-A, five consecutive volume scans will be obtained in these regions, each containing 216 A-scans. These images will be registered, and the consecutive B-scans will be used to calculate the decorrelation among the images to provide split-spectrum amplitude decorrelation angiography (SSADA) images. This decorrelation between consecutive B-scan images will be used to highlight locations where there is blood flow. The density of the perfused peripapillary vessels within the various layers of the retina will be calculated to create a flow density map.

Studietype

Intervensjonell

Registrering (Antatt)

16

Fase

  • Fase 1

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Studiesteder

    • Texas
      • Houston, Texas, Forente stater, 77058
        • Rekruttering
        • Johnson Space Center
        • Ta kontakt med:
          • Eden Fields

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

20 år til 100 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

• Must be astronauts selected for 6-12 month missions on the International Space Station

Exclusion Criteria:

• Subjects taking B-vitamin supplements

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Supplemented with B-Complex

Subjects will take a vitamin B-complex supplement before, during, and after a 6-12 month spaceflight on the International Space Station

Vitamin B-Complex Supplement containing: 5-methyltetrahydrofolate, riboflavin 5 phosphate, pyridoxal phosphate, and methylcobalamin

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Optic Disc Edema
Tidsramme: 6 months

Measure change in total retinal thickness during and after flight compared to preflight using OCT

6 months

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Endothelial function
Tidsramme: 6 months

Assess reactive hyperemia through changes in fingertip temperature

6 months
Advanced Glycation End Products (AGE)
Tidsramme: 6 months

Skin autofluorescence (SAF) will be analyzed non-invasively using an AGE reader

6 months
Serum folate status
Tidsramme: 6 months

Vitamin status assessed from a fasting blood sample

6 months
Red Blood Cell folate status
Tidsramme: 6 months

Vitamin status assessed from a fasting blood sample

6 months
Vitamin B6 status
Tidsramme: 6 months

Vitamin status assessed from a fasting blood sample

6 months
Vitamin B12 status
Tidsramme: 6 months

Vitamin status assessed from a fasting blood sample

6 months
Glucose
Tidsramme: 6 months

Serum glucose from a fasting blood sample

6 months
Nitric oxide
Tidsramme: 6 months

Serum nitric oxide from a fasting blood sample

6 months
tetrahydrobiopterin
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Dihydrobiopterin
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Oxidized glutathione
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Total antioxidant capacity
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Advanced glycation end products
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Albumin
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Glycated albumin
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
3-nitrotyrosine
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Formate
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
MMP-2
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
MMP-9
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
TIMP-1
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
TIMP-2
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Heparan sulfate
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Syndecan-1
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Glypican
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Hyaluronan
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months
Total lipid peroxides
Tidsramme: 6 months

Serum biochemistry from a fasting blood sample

6 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Samarbeidspartnere

Etterforskere

  • Hovedetterforsker: Sara R Zwart, PhD, UTMB

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. august 2022

Primær fullføring (Antatt)

1. juli 2032

Studiet fullført (Antatt)

30. september 2035

Datoer for studieregistrering

Først innsendt

29. april 2022

Først innsendt som oppfylte QC-kriteriene

5. mai 2022

Først lagt ut (Faktiske)

9. mai 2022

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

12. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

9. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • NASA IRB STUDY00000448

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Ja

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere